On the public citation graph
Identification and Selection of “Privileged Fragments” Suitable for Primary Screening
0 signed · 77 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1521-3773(19990614)38:12<1784::aid-anie1784>3.0.co;2-qopenalex-snapshot
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy
inferredcites →https://doi.org/10.1002/cbic.200400188openalex-snapshot
The Discovery of Novel Protein Kinase Inhibitors by Using Fragment‐Based High‐Throughput X‐ray Crystallography
inferredcites →https://doi.org/10.1007/bf01718702openalex-snapshot
Optimization and visualization of molecular diversity of combinatorial libraries
inferredcites →https://doi.org/10.1016/j.bmc.2006.07.050openalex-snapshot
Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design
inferredcites →https://doi.org/10.1016/j.cbpa.2004.05.002openalex-snapshot
Using NMR for ligand discovery and optimization
inferredcites →https://doi.org/10.1016/j.cbpa.2005.05.002openalex-snapshot
Fragonomics: fragment-based drug discovery
inferredcites →https://doi.org/10.1016/j.chembiol.2004.12.004openalex-snapshot
TINS, Target Immobilized NMR Screening: An Efficient and Sensitive Method for Ligand Discovery
inferredcites →https://doi.org/10.1016/j.compbiolchem.2004.11.003openalex-snapshot
Assessment of chemical libraries for their druggability
inferredcites →https://doi.org/10.1016/s0076-6879(05)94023-8openalex-snapshot
Utilization of NMR-Derived Fragment Leads in Drug Design
inferredcites →https://doi.org/10.1016/s0169-409x(02)00003-0openalex-snapshot
Prediction of ‘drug-likeness’
inferredcites →https://doi.org/10.1016/s1056-8719(00)00107-6openalex-snapshot
Drug-like properties and the causes of poor solubility and poor permeability
inferredcites →https://doi.org/10.1016/s1074-5521(00)80022-8openalex-snapshot
The SHAPES strategy: an NMR-based approach for lead generation in drug discovery
inferredcites →https://doi.org/10.1016/s1359-6446(03)02740-5openalex-snapshot
Chemical substructures in drug discovery
inferredcites →https://doi.org/10.1016/s1359-6446(03)02831-9openalex-snapshot
A ‘Rule of Three’ for fragment-based lead discovery?
inferredcites →https://doi.org/10.1016/s1359-6446(99)01451-8openalex-snapshot
Computational methods for the prediction of ‘drug-likeness’
inferredcites →https://doi.org/10.1016/s1367-5931(03)00062-0openalex-snapshot
High-throughput crystallography to enhance drug discovery
inferredcites →https://doi.org/10.1021/bi060173mopenalex-snapshot
Structure-Guided Design of Peptide-Based Tryptase Inhibitors
inferredcites →https://doi.org/10.1021/ci000392topenalex-snapshot
Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices
inferredcites →https://doi.org/10.1021/ci00068a019openalex-snapshot
Models for the representation of knowledge about chemical reactions
inferredcites →https://doi.org/10.1021/ci0100649openalex-snapshot
New Diversity Calculations Algorithms Used for Compound Selection
inferredcites →https://doi.org/10.1021/ci010366aopenalex-snapshot
Is There a Difference between Leads and Drugs? A Historical Perspective
inferredcites →https://doi.org/10.1021/ci049714+openalex-snapshot
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
inferredcites →https://doi.org/10.1021/ci049806zopenalex-snapshot
Design and Characterization of Libraries of Molecular Fragments for Use in NMR Screening against Protein Targets
inferredcites →https://doi.org/10.1021/ci970429iopenalex-snapshot
RECAPRetrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry
inferredcites →https://doi.org/10.1021/ja038128eopenalex-snapshot
A General NMR Method for Rapid, Efficient, and Reliable Biochemical Screening
inferredcites →https://doi.org/10.1021/ja039480vopenalex-snapshot
SOS-NMR: A Saturation Transfer NMR-Based Method for Determining the Structures of Protein−Ligand Complexes
inferredcites →https://doi.org/10.1021/jm000373aopenalex-snapshot
Design of Adenosine Kinase Inhibitors from the NMR-Based Screening of Fragments
inferredcites →https://doi.org/10.1021/jm000942eopenalex-snapshot
Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties
inferredcites →https://doi.org/10.1021/jm010927popenalex-snapshot
SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2
inferredcites →https://doi.org/10.1021/jm020160gopenalex-snapshot
NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability
inferredcites →https://doi.org/10.1021/jm0305117openalex-snapshot
Non-Peptidic Small-Molecule Inhibitors of the Single-Chain Hepatitis C Virus NS3 Protease/NS4A Cofactor Complex Discovered by Structure-Based NMR Screening
inferredcites →https://doi.org/10.1021/jm034088dopenalex-snapshot
Selective Protein Tyrosine Phosphatase 1B Inhibitors: Targeting the Second Phosphotyrosine Binding Site with Non-Carboxylic Acid-Containing Ligands
inferredcites →https://doi.org/10.1021/jm034122oopenalex-snapshot
Fragment Screening and Assembly: A Highly Efficient Approach to a Selective and Cell Active Protein Tyrosine Phosphatase 1B Inhibitor
inferredcites →https://doi.org/10.1021/jm049131ropenalex-snapshot
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data
inferredcites →https://doi.org/10.1021/jm049575nopenalex-snapshot
Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
inferredcites →https://doi.org/10.1021/jm0495778openalex-snapshot
Fragment-Based Lead Discovery Using X-ray Crystallography
inferredcites →https://doi.org/10.1021/jm060838iopenalex-snapshot
Automatic and Efficient Decomposition of Two-Dimensional Structures of Small Molecules for Fragment-Based High-Throughput Docking
inferredcites →https://doi.org/10.1021/jm061197uopenalex-snapshot
Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase
inferredcites →https://doi.org/10.1021/jm9602928openalex-snapshot
The Properties of Known Drugs. 1. Molecular Frameworks
inferredcites →https://doi.org/10.1021/jm9903996openalex-snapshot
Properties of Known Drugs. 2. Side Chains
inferredcites →https://doi.org/10.1021/jp980230oopenalex-snapshot
Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods
inferredcites →https://doi.org/10.1021/js960177kopenalex-snapshot
Prediction of Distribution Coefficient from Structure. 1. Estimation Method
inferredcites →https://doi.org/10.1023/a:1008354229396openalex-snapshot
Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water*
inferredcites →https://doi.org/10.1023/a:1013302231549openalex-snapshot
WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability
inferredcites →https://doi.org/10.1023/a:1020877402759openalex-snapshot
Current trends in lead discovery: Are we looking for the appropriate properties?
inferredcites →https://doi.org/10.1038/nchembio831openalex-snapshot
Deconstructing fragment-based inhibitor discovery
inferredcites →https://doi.org/10.1177/108705702237674openalex-snapshot
A Strategy for High-Throughput Assay Development Using Leads Derived from Nuclear Magnetic Resonance-Based Screening
inferredcites →https://doi.org/10.2174/1386207023329941openalex-snapshot
Utility of NMR in Lead Optimization: Fragment-Based Approaches
inferredcites →https://doi.org/10.2174/1389557043487385openalex-snapshot
New Lead Generation Strategies for Protein Kinase Inhibitors - Fragment Based Screening Approaches
inferredcites →https://doi.org/10.2174/1568026033392606openalex-snapshot
Design of Small Molecule Libraries for NMR Screening and Other Applications in Drug Discovery
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9783527683604.ch09openalex-snapshot
Computational Methods to Support Fragment‐based Drug Discovery
inferred← citeshttps://doi.org/10.1002/9783527805297.ch6openalex-snapshot
Automated Data Evaluation in Life Sciences
inferred← citeshttps://doi.org/10.1002/9783527822843.ch6openalex-snapshot
Automatisierte Datenauswertung in den Lifesciences
inferred← citeshttps://doi.org/10.1002/9783527829446.ch12openalex-snapshot
Laboratory Automation Software
inferred← citeshttps://doi.org/10.1002/chin.200915214openalex-snapshot
ChemInform Abstract: Identification and Selection of “Privileged Fragments” Suitable for Primary Screening.
inferred← citeshttps://doi.org/10.1002/minf.201700042openalex-snapshot
Multi‐target Fragments Display Versatile Binding Modes
inferred← citeshttps://doi.org/10.1007/128_2011_182openalex-snapshot
Fragment-Based Approaches and Computer-Aided Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-1-60761-839-3_16openalex-snapshot
Methods for Combinatorial and Parallel Library Design
inferred← citeshttps://doi.org/10.1007/s10822-011-9461-xopenalex-snapshot
Design of a Fragment Library that maximally represents available chemical space
inferred← citeshttps://doi.org/10.1007/s10822-016-9899-yopenalex-snapshot
Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design
inferred← citeshttps://doi.org/10.1007/s10822-025-00730-0openalex-snapshot
Chasing allosteric inhibition of the SARS-CoV-2 PLpro via molecular dynamics simulations with flooding fragments (MDFFr)
inferred← citeshttps://doi.org/10.1016/j.bmc.2024.117826openalex-snapshot
Synthesis and biological evaluation of O4′-benzyl-hispidol derivatives and analogs as dual monoamine oxidase-B inhibitors and anti-neuroinflammatory agents
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.11.019openalex-snapshot
Fragment-based discovery of novel and selective mPGES-1 inhibitors Part 1: Identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid
inferred← citeshttps://doi.org/10.1016/j.coph.2009.04.009openalex-snapshot
Recent progress in fragment-based lead discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00949openalex-snapshot
Phenotypic Screening for Targeted Protein Degradation: Strategies, Challenges, and Emerging Opportunities
inferred← citeshttps://doi.org/10.1021/bk-2016-1222.ch016openalex-snapshot
The Many Facets of Screening Library Design
inferred← citeshttps://doi.org/10.1021/jm901361dopenalex-snapshot
Small Molecules and Stem Cells. Potency and Lineage Commitment: The New Quest for the Fountain of Youth
inferred← citeshttps://doi.org/10.1177/2211068216672613openalex-snapshot
Generic and Automated Data Evaluation in Analytical Measurement
inferred← citeshttps://doi.org/10.1186/s13321-021-00526-yopenalex-snapshot
“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool
inferred← citeshttps://doi.org/10.2174/092986712800167356openalex-snapshot
Privileged Structures - Dream or Reality: Preferential Organization of Azanaphthalene Scaffold
inferred← citeshttps://doi.org/10.2174/156802612804547371openalex-snapshot
Computational Tools for In Silico Fragment-Based Drug Design
inferred← citeshttps://doi.org/10.3389/fimmu.2021.642383openalex-snapshot
Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
inferred← citeshttps://doi.org/10.3390/ijms20061375openalex-snapshot
The Light and Dark Sides of Virtual Screening: What Is There to Know?
inferred← citeshttps://doi.org/10.4155/fmc.10.277openalex-snapshot
Computational Medicinal Chemistry in Fragment-Based Drug Discovery: What, How and When
inferred← citeshttps://doi.org/10.6084/m9.figshare.15047880openalex-snapshot
Additional file 1 of “Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.